BioCardia, Inc. (BCDA) has a negative trailing P/E of -1.5, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -65.08%.
Criteria proven by this page:
Overall SharesGrow Score: 47/100 with 2/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | -31.6 | 0.05 | 15.81 | 565.08 | - |
| 2017 | -21.9 | 0.30 | 24.18 | 561.65 | - |
| 2018 | -9.9 | -0.81 | 36.43 | 221.06 | - |
| 2019 | -4.2 | 0.21 | 26.29 | 87.77 | - |
| 2020 | -7.0 | 0.16 | 5.48 | 724.36 | - |
| 2021 | -7.8 | 0.16 | 9.49 | 97.02 | - |
| 2022 | -9.3 | 0.92 | 22.71 | 82.15 | - |
| 2023 | -1.2 | 0.07 | -8.77 | 29.48 | - |
| 2024 | -0.8 | 0.01 | 7.15 | 103.14 | - |
| 2025 | -1.0 | 0.02 | 9.31 | 0.00 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $-166.33 | $576K | $-10.31M | -1789.9% |
| 2017 | $-43.50 | $479K | $-12.31M | -2569.5% |
| 2018 | $-48.80 | $625K | $-13.99M | -2237.9% |
| 2019 | $-39.15 | $710K | $-14.71M | -2071.7% |
| 2020 | $-22.20 | $145K | $-15M | -10347.6% |
| 2021 | $-11.19 | $1.02M | $-12.62M | -1243.4% |
| 2022 | $-10.05 | $1.35M | $-11.91M | -881.1% |
| 2023 | $-8.19 | $477K | $-11.57M | -2425.8% |
| 2024 | $-2.90 | $58K | $-7.95M | -13700% |
| 2025 | $-1.23 | $0.00 | $-8.23M | - |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $-0.63 | $-0.63 – $-0.63 | $50K | $50K – $50K | 1 |
| 2027 | $-0.51 | $-0.51 – $-0.51 | $50K | $50K – $50K | 1 |
| 2028 | $-0.39 | $-0.40 – $-0.38 | $4.15M | $4.15M – $4.15M | 2 |
